CIK: 0001792126
申告総資産額
$20.0億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | 株式-ヘルスケア | 7.70% | — | — | |
| 2 | SRPT | Sarepta Therapeutics INC | 株式-ヘルスケア | 6.97% | — | -17.10% | |
| 3 | MYOKEUR | Myokardia INC | 株式-その他 | 5.35% | — | +29.87% | |
| 4 | MRNA | Moderna INC | 株式-ヘルスケア | 5.24% | — | — | |
| 5 | ASND | Ascendis Pharma A/S | 株式-その他 | 5.14% | — | -33.30% | |
| 6 | RETAEUR | Reata Pharmaceuticals Inc-a | 株式-その他 | 4.52% | — | +47.74% | |
| 7 | BMY | Bristol-myers Squibb Co | 株式-ヘルスケア | 4.12% | — | — | |
| 8 | ZYMEUSD | Zymeworks INC | 株式-その他 | 4.11% | — | -21.77% | |
| 9 | 1K0 | Igm Biosciences INC | 株式-その他 | 3.71% | — | +51.97% | |
| 10 | GBTUSD | Global Blood Therapeutics In | 株式-その他 | 3.61% | — | — | |
| 11 | ✓ | Passage Bio INC | 株式-その他 | 3.41% | — | — | |
| 12 | VRTX | Vertex Pharmaceuticals INC | 株式-ヘルスケア | 3.01% | — | — | |
| 13 | BLU | Bellus Health INC | 株式-その他 | 2.94% | — | +82.61% | |
| 14 | IOVA | Iovance Biotherapeutics INC | 株式-その他 | 2.82% | — | +12.11% | |
| 15 | FULC | Fulcrum Therapeutics INC | 株式-その他 | 2.42% | — | +330.72% | |
| 16 | ETNBGBP | 89bio INC | 株式-その他 | 2.37% | — | +185.25% | |
| 17 | MRTXEUR | Mirati Therapeutics INC | 株式-その他 | 2.33% | — | -87.99% | |
| 18 | ✓ | Molecular Templates Inc | 株式-その他 | 2.22% | — | +29.11% | |
| 19 | ✓ | Veralto CORP | 株式-その他 | 2.10% | — | — | |
| 20 | ✓ | 株式-その他 | 1.91% | — | +75.70% | ||
| 21 | BMY-R | Bristol-myers Squibb-cvr | 株式-その他 | 1.84% | — | -61.61% | |
| 22 | TXG | 10x Genomics Inc-class A | 株式-その他 | 1.73% | — | — | |
| 23 | CRSP | CRISPR Therapeutics AG | 株式-ヘルスケア | 1.70% | — | — | |
| 24 | 2655787D | Blueprint Medicines CORP | 株式-その他 | 1.67% | — | — | |
| 25 | ALNY | Alnylam Pharmaceuticals INC | 株式-ヘルスケア | 1.64% | — | — | |
| 26 | FATE | Fate Therapeutics INC | 株式-その他 | 1.63% | — | — | |
| 27 | AM6 | Amicus Therapeutics INC | 株式-その他 | 1.57% | — | — | |
| 28 | TREUR | Trillium Therapeutics INC | 株式-その他 | 1.53% | — | — | |
| 29 | ✓ | Lifesci Acquisition CORP | 株式-その他 | 1.52% | — | — | |
| 30 | ZGNXEUR | Zogenix INC | 株式-その他 | 1.43% | — | -46.99% | |
| 31 | IMMU | Immunomedics INC | 株式-その他 | 1.42% | — | — | |
| 32 | BDTX | Black Diamond Therapeutics I | 株式-その他 | 1.05% | — | — | |
| 33 | SELBUSD | Cartesian Therapeutics INC | 株式-その他 | 1.02% | — | — | |
| 34 | TGTX | Tg Therapeutics INC | 株式-ヘルスケア | 0.93% | — | — | |
| 35 | CYTK | Cytokinetics INC | 株式-ヘルスケア | 0.87% | +1.73% | — | |
| 36 | SG7 | Sage Therapeutics INC | 株式-その他 | 0.76% | — | -63.40% | |
| 37 | NERVGBP | Minerva Neurosciences INC | 株式-その他 | 0.71% | — | +35.95% | |
| 38 | SVRA | Savara INC | 株式-その他 | 0.45% | — | — | |
| 39 | RVMD | Revolution Medicines INC | 株式-ヘルスケア | 0.44% | -4.73% | — | |
| 40 | RCKT | Rocket Pharmaceuticals INC | 株式-その他 | 0.08% | — | -92.92% |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | 1K0 | Igm Biosciences INC | +2.6% | +51.97% | 増加 |
| 2 | BLU | Bellus Health INC | +2.1% | +82.61% | 増加 |
| 3 | FULC | Fulcrum Therapeutics INC | +1.9% | +330.72% | 増加 |
| 4 | ETNBGBP | 89bio INC | +1.8% | +185.25% | 増加 |
| 5 | MYOKEUR | Myokardia INC | +1.2% | +29.87% | 増加 |
| 6 | ✓ | +1.2% | +75.70% | 増加 | |
| 7 | SRPT | Sarepta Therapeutics INC | -0.2% | -17.10% | 減少 |
| 8 | ZYMEUSD | Zymeworks INC | -0.3% | -21.77% | 減少 |
| 9 | BMY-R | Bristol-myers Squibb-cvr | -0.6% | -61.61% | 減少 |
| 10 | ASND | Ascendis Pharma A/S | -1% | -33.30% | 減少 |
| 11 | RCKT | Rocket Pharmaceuticals INC | -1.2% | -92.92% | 減少 |
| 12 | ZGNXEUR | Zogenix INC | -2.3% | -46.99% | 減少 |
| 13 | SG7 | Sage Therapeutics INC | -2.6% | -63.40% | 減少 |
| 14 | MRTXEUR | Mirati Therapeutics INC | -18.8% | -87.99% | 減少 |
| 15 | ✓ | Amarin Corp PLC | — | EXIT | 全売却 |
| 16 | ABBV | Abbvie INC | — | NEW | 新規購入 |
| 17 | APLSUSD | Apellis Pharmaceuticals INC | — | EXIT | 全売却 |
| 18 | ✓ | — | EXIT | 全売却 | |
| 19 | XLRN | Acceleron Pharma INC | — | EXIT | 全売却 |
| 20 | MRNA | Moderna INC | — | NEW | 新規購入 |
| 21 | AXSM | Axsome Therapeutics INC | — | EXIT | 全売却 |
| 22 | BMY | Bristol-myers Squibb Co | — | NEW | 新規購入 |
| 23 | BHVN | Biohaven Ltd. | — | EXIT | 全売却 |
| 24 | QURE | uniQure N.V. | — | EXIT | 全売却 |
| 25 | GBTUSD | Global Blood Therapeutics In | — | NEW | 新規購入 |
| 26 | ✓ | Passage Bio INC | — | NEW | 新規購入 |
| 27 | VRTX | Vertex Pharmaceuticals INC | — | NEW | 新規購入 |
| 28 | CCXIEUR | Chemocentryx INC | — | EXIT | 全売却 |
| 29 | KDMN | Kadmon Holdings INC | — | EXIT | 全売却 |
| 30 | ✓ | Veralto CORP | — | NEW | 新規購入 |
| 31 | SWTXUSD | Springworks Therapeutics INC | — | EXIT | 全売却 |
| 32 | CNST | Constellation Pharmaceutical | — | EXIT | 全売却 |
| 33 | TXG | 10x Genomics Inc-class A | — | NEW | 新規購入 |
| 34 | OPHTEUR | Iveric Bio INC | — | EXIT | 全売却 |
| 35 | CRSP | CRISPR Therapeutics AG | — | NEW | 新規購入 |
| 36 | 2655787D | Blueprint Medicines CORP | — | NEW | 新規購入 |
| 37 | ALNY | Alnylam Pharmaceuticals INC | — | NEW | 新規購入 |
| 38 | FATE | Fate Therapeutics INC | — | NEW | 新規購入 |
| 39 | AM6 | Amicus Therapeutics INC | — | NEW | 新規購入 |
| 40 | TREUR | Trillium Therapeutics INC | — | NEW | 新規購入 |
| 41 | ✓ | Lifesci Acquisition CORP | — | NEW | 新規購入 |
| 42 | ASMB | Assembly Biosciences, Inc. | — | EXIT | 全売却 |
| 43 | IMMU | Immunomedics INC | — | NEW | 新規購入 |
| 44 | ✓ | — | EXIT | 全売却 | |
| 45 | MEIPUSD | Lite Strategy INC | — | EXIT | 全売却 |
| 46 | BDTX | Black Diamond Therapeutics I | — | NEW | 新規購入 |
| 47 | SELBUSD | Cartesian Therapeutics INC | — | NEW | 新規購入 |
| 48 | MDGL | Madrigal Pharmaceuticals INC | — | EXIT | 全売却 |
| 49 | TGTX | Tg Therapeutics INC | — | NEW | 新規購入 |
| 50 | CYTK | Cytokinetics INC | — | NEW | 新規購入 |